loss treatment press releases looked great greenway remembers shortly drug released europe reports rimonabant related suicides began trickling drug never approved u.s. later recalled europe result fda likely view new antiobesity drugs caution july fda advisory panel narrowly voted qnexa citing concerns effects fda not required act panel recommendation ed j. hendricks physician runs weight loss center sacramento California hopes drugs approved pathways obesity better understood drugs getting specific says question act specifically prove safe wide use 4 hours ago robin lloyd | 7 hours ago tanya lewis josh fischman jeffery delviscio sunya bhutta 8 hours ago eli m. cahan